LOVE.CN - Cannara Biotech Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1700
0.0000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.1700
Open0.1800
Bid0.1700 x 0
Ask0.1800 x 0
Day's Range0.1700 - 0.1800
52 Week Range0.0500 - 0.3450
Volume465,094
Avg. Volume505,855
Market Cap118.111M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0120
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trade Resumption - LOVE

    IIROC Trade Resumption - LOVE

  • CNW Group

    Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

    VANCOUVER , Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (OTCQB:LOVFF) (8CB.F), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of  premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec . With construction recently completed, Phase One consists of 170,000 square feet, of which 110,000 is dedicated to indoor cultivation with a capacity of 20,000 kg of premium dried cannabis once the cultivation license is granted. The facility is situated on 27-acres of land located 45 minutes from Montreal and both the facility and the license are held through wholly owned subsidiaries of Cannara Biotech Inc.

  • CNW Group

    IIROC Trading Halt - LOVE

    IIROC Trading Halt - LOVE

  • PR Newswire

    Cannara Announces Appointment of New Chief Operating Officer

    VANCOUVER, Aug. 15, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (OTCQB:LOVFF) (8CB.F), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. "We are excited to welcome Barry to the leadership team, knowing his contributions will help accelerate our company to its next stage of growth," said Zohar Krivorot, President and CEO of Cannara. Barry will replace Evan Morris, who has helped bring the construction phase of our Farnham facility to completion.

  • CNW Group

    OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing

    OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing

  • PR Newswire

    Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, British Columbia , ...

  • PR Newswire

    Live OTCQB Venture Company Investor Conference August 1st

    Company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , July 30, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for ...

  • CNW Group

    Cannara Biotech Inc. Reports Q3 2019 Results

    VANCOUVER , July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (OTCQB:LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019. Closed a Global shopCBD.com Inc. financing in excess of $8 million to support the launch of the online e-commerce platform for the sale and distribution, in the US, of hemp-based CBD products. Subsequent to the quarter, the Company further strengthened its balance sheet with a $2.1 million private placement.

  • CNW Group

    Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

    Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

  • CNW Group

    Horizons ETFs Rebalances Marijuana-Focused ETFs

    Horizons ETFs Rebalances Marijuana-Focused ETFs

  • Market Exclusive

    Cannabis Stock News Daily Roundup May 28

    CannTrust Holdings (TSX: TRST) (NYSE: CTST) has launched a cannabis education portal together with Well.ca. The resource is available to Ontario residents through Well.ca with additional provinces to launch soon. Well.ca will serve as a resource and education center for those interested in exploring medical cannabis, leveraging content, insights and expertise from CannTrust's medical business. […]The post Cannabis Stock News Daily Roundup May 28 appeared first on Market Exclusive.

  • CNW Group

    Cannara Biotech Appoints Dr. Sara May to its Board of Directors

    VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May , PhD. Dr. May is recognized as an expert in the medical cannabis sector and will bring  additional skill sets and help strengthen  the Company's Board.

  • CNW Group

    Cannara Biotech Commences Trading on the OTCQB Market in the United States

    VANCOUVER , May 15, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the  trading symbol "CNBTF". The OTC operates financial markets for approximately 10,000 U.S. and global securities.  "Cannabis and hemp-CBD markets are global markets, with customers, vendors and investors domiciled across all major industrial nations," said Zohar Krivorot, President and CEO of Cannara.

  • GlobeNewswire

    PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES

    SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has.

  • PR Newswire

    Cannara Biotech Reports Q2 2019 Results

    VANCOUVER , April 29, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation ...